TG Therapeutics Q3 EPS $(0.69) May Not Compare To $(0.34) Estimate

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.34) by 102.94 percent. This is a 60.47 percent decrease over losses of $(0.43) per share

Benzinga · 11/12/2019 12:38

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.34) by 102.94 percent. This is a 60.47 percent decrease over losses of $(0.43) per share from the same period last year.